Beam Therapeutics Inc. Annual Share-based Payment Arrangement, Expense in USD from 2019 to 2023

Taxonomy & unit
us-gaap: USD
Description
Amount of expense for award under share-based payment arrangement. Excludes amount capitalized.
Summary
Beam Therapeutics Inc. quarterly/annual Share-based Payment Arrangement, Expense history and growth rate from 2019 to 2023.
  • Beam Therapeutics Inc. Share-based Payment Arrangement, Expense for the quarter ending June 30, 2024 was $31.6M, a 20.3% increase year-over-year.
  • Beam Therapeutics Inc. Share-based Payment Arrangement, Expense for the twelve months ending June 30, 2024 was $109M, a 15.2% increase year-over-year.
  • Beam Therapeutics Inc. annual Share-based Payment Arrangement, Expense for 2023 was $98.6M, a 17% increase from 2022.
  • Beam Therapeutics Inc. annual Share-based Payment Arrangement, Expense for 2022 was $84.3M, a 93.5% increase from 2021.
  • Beam Therapeutics Inc. annual Share-based Payment Arrangement, Expense for 2021 was $43.6M, a 183% increase from 2020.
Share-based Payment Arrangement, Expense, Trailing 12 Months (USD)
Share-based Payment Arrangement, Expense, Annual (USD)
Share-based Payment Arrangement, Expense, YoY Annual Growth (%)
Period Value YoY Chg Change % Start Date End Date Report Filed
2023 $98.6M +$14.3M +17% Jan 1, 2023 Dec 31, 2023 10-K 2024-02-27
2022 $84.3M +$40.8M +93.5% Jan 1, 2022 Dec 31, 2022 10-K 2024-02-27
2021 $43.6M +$28.2M +183% Jan 1, 2021 Dec 31, 2021 10-K 2024-02-27
2020 $15.4M +$8.35M +119% Jan 1, 2020 Dec 31, 2020 10-K 2023-02-28
2019 $7.03M Jan 1, 2019 Dec 31, 2019 10-K 2022-02-28
* An asterisk sign (*) next to the value indicates that the value is likely invalid.